News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Dr. Carles Domènech, CEO y cofundador de AbilityPharma
AbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous non-small cell lung cancer
Healthcare · Innovative drugs · Advanced therapies
These results support ibrilatazar as a potential backbone therapy for patients with one of the most…
Partners - Ability Pharmaceuticals
Reunión de equipo valorando resultados económicos
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
Healthcare · Access to innovation
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory…
Partners - THERIVA BIOLOGICS S.L.
N-GENE
Genetics Becomes an Ally for Healthcare Professionals
Healthcare · Access to innovation · Digitalization
Personalized medicine is no longer a promise—it's a reality, with genetics as its key ally. To…
Partners - ADNTRO GENETICS SL
BCN HEALTH publica un estudio que pone de relieve los elevados costes sanitarios asociados al carcinoma hepatocelular en España
BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with hepatocellular carcinoma in Spain
Healthcare · Access to innovation
BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs…
Partners - BCN Health
Francisco Alcain, CIO de Natac, recogió el premio 'Empresa Extremeña' del Grupo Ros.
Natac wins the 'Extremadura Company Award' granted by the Ros Group
Corporate
The award recognises the company's track record, innovation and contribution to the economic and…
Partners - Natac Group
Claudio Hidalgo Cantabrana
#NewAseBioMember | “#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute to science through the biotechnology sector””
Healthcare · Corporate
Meet our new member Microviable Therapeutics .  We sponke with Claudio Hidalgo Cantabrana, CEO…
AseBio - MICROVIABLE THERAPEUTICS
Banner del webinar organizado por BioDuro
BioDuro hosts webinar: "Exploring Peptide In-Vitro ADME Properties – From Natural Peptides to Synthetic Analogues"
Healthcare · Drug discovery · Innovative drugs · Advanced therapies
The webinar exploring the in-vitro ADME (Absorption, Distribution, Metabolism, and Excretion)…
Partners - BIODURO
Mireia Forner, Medical Head Neurología en Sanofi Iberia
World Multiple Sclerosis Day | “The integration of biotechnology and AI allows us to move towards increasingly precise and timely treatments”
Healthcare · Personalized medicine · Advanced therapies
Interview with Mireia Forner, Medical Head of Neurology at Sanofi Iberia, a company working to…
AseBio - SANOFI
Equipo de Altum Sequencing
Detecting the Undetectable: How Altum Sequencing Is Transforming Acute Myeloid Leukemia Monitoring
Healthcare · Personalized medicine
We demonstrated that our assay could detect residual disease in AML patients after treatment with…
Partners - Altum Sequencing